Myfortic (Mycophenolic Acid)

Mycophenolic acid, the active ingredient in Myfortic, is an antimetabolite immunosuppressant presented as an oral formulation for oral use. It works by inhibiting a key enzyme in lymphocyte proliferation, thereby reducing the risk of organ rejection. Myfortic is indicated for the prevention of rejection in kidney, heart and liver transplant recipients, helping to maintain graft function and improve patient outcomes.

GNH USA supplies Myfortic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Myfortic is employed in the immunosuppressive management of solid‑organ transplantation, targeting the immune pathways that lead to graft rejection.

- Kidney transplant: helps prevent acute and chronic rejection of the transplanted kidney. - Heart transplant: reduces the likelihood of immune‑mediated damage to the donor heart. - Liver transplant: supports graft survival by suppressing T‑cell activation.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: increased loose stools. - Abdominal pain: discomfort in the stomach area. - Headache: transient cranial pain. - Tremor: fine shaking of hands or limbs. - Infections: increased susceptibility to common infections.

Serious or Rare Side Effects: - Leukopenia: significant reduction in white blood cells. - Anemia: decreased red blood cell count. - Severe infection: opportunistic or life‑threatening infections. - Hepatic dysfunction: abnormal liver enzyme elevations. - Malignancy: increased risk of certain cancers. - Progressive multifocal leukoencephalopathy: rare brain infection.

Patients should be monitored closely for safety and efficacy.

- Blood counts: monitor complete blood count regularly to detect leukopenia or anemia. - Renal function: assess kidney function before and during therapy. - Infection risk: avoid initiating therapy in the presence of active infections. - Pregnancy: discuss potential risks with a healthcare professional before use. - Contraception: advise women of child‑bearing potential to use effective contraception. - Store at room temperature: keep in the original container, protect from moisture and heat.

Myfortic may interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Live vaccines: increased risk of vaccine‑derived infection. - Cholestyramine or other bile‑acid sequestrants: may reduce drug absorption.

Moderate Interactions (Monitor Closely): - Cyclosporine or tacrolimus: may increase mycophenolic acid exposure. - Warfarin: potential alteration of anticoagulant effect. - Statins: heightened risk of myopathy. - NSAIDs: may exacerbate renal toxicity.